Verrica Pharmaceuticals (VRCA) Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. MONC:IM
2. PSKY
3. MONRY
4. PTON
5. NYXH
6. TDY
7. PNR
8. ACN
9. ONON
10. IAUX

Go back to Verrica Pharmaceuticals (VRCA) Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315
(NASDAQ: VRCA) Delayed: 4.49 --0 (-0%)
Previous Close $4.49    52 Week High $ 
Open $4.49    52 Week Low $ 
Day High $4.49    P/E N/A 
Day Low $4.49    EPS $ 
Volume 10